Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.

Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.

Item
http://www.wikidata.org/entity/Q33413067
The under reporting of recruitment strategies in research with children with life-threatening illnesses: A systematic reviewRelapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study.A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's OncoloPhase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease.Effect of O6-methylguanine-DNA methyltransferase methylation in medulloblastoma.Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.Sophoridine suppresses cell growth in human medulloblastoma through FoxM1, NF-κB and AP-1.A primitive neuroectodermal tumor in an adult: Case report of a unique location and MRI characteristics.Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response.Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression.
P2860

Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.

Item
http://www.wikidata.org/entity/Q33413067
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Temozolomide is an active agen ...... -institutional phase II trial.
@ast
Temozolomide is an active agen ...... -institutional phase II trial.
@en
type
label
Temozolomide is an active agen ...... -institutional phase II trial.
@ast
Temozolomide is an active agen ...... -institutional phase II trial.
@en
prefLabel
Temozolomide is an active agen ...... -institutional phase II trial.
@ast
Temozolomide is an active agen ...... -institutional phase II trial.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Temozolomide is an active agen ...... -institutional phase II trial.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932